Xiaoling Cao

Xiaoling Cao

Auto-generated profile, based on publicly available information

Xiaoling Cao

Department of Plastic Surgery The First Affiliated Hospital of Sun Yat‐sen University Guangzhou China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in Journal of Clinical Lipidology
Verified
Journal Article
Closed access
XWXiuqi Wei
Xiuqi Wei
WZWenjuan Zeng
Wenjuan Zeng
JSJingyu Su
Jingyu Su
HWHuimin Wan
Huimin Wan
XYXinqin Yu
Xinqin Yu
HWHui Wang
Hui Wang

21 June 2023 in Nature
Verified
Journal Article
Open access
PDF file
XWXiaojie Wang
Xiaojie Wang
RRRaul Ramos
Raul Ramos
APAnne Q. Phan
Anne Q. Phan
KYKosuke Yamaga
Kosuke Yamaga
JFJessica L. Flesher
Jessica L. Flesher
MPMaksim V. Plikus
Maksim V. Plikus
Niche signals maintain stem cells in a prolonged quiescence or transiently activate them for proper regeneration1. Altering balanced niche signalling can lead to regenerative disorders. Melanocytic skin nevi in human often display excessive hair growth, suggesting hair stem cell hyperactivity. Here, using genetic mouse models of nevi2,3, we show that dermal clusters of senescent melanocytes drive epithelial hair stem cells to exit quiescence and change their transcriptome and composition, potently enhancing hair renewal. Nevus melanocytes activate a distinct secretome, enriched for signalling factors. Osteopontin, the leading nevus signalling factor, is both necessary and sufficient to induce hair growth. Injection of osteopontin or its genetic overexpression is sufficient to induce robust hair growth in mice, whereas germline and conditional deletions of either osteopontin or CD44, its cognate receptor on epithelial hair cells, rescue enhanced hair growth induced by dermal nevus melanocytes. Osteopontin is overexpressed in human hairy nevi, and it stimulates new growth of human hair follicles. Although broad accumulation of senescent cells, such as upon ageing or genotoxic stress, is detrimental for the regenerative capacity of tissue4, we show that signalling by senescent cell clusters can potently enhance the activity of adjacent intact stem cells and stimulate tissue renewal. This finding identifies senescent cells and their secretome as an attractive therapeutic target in regenerative disorders.

1 July 2020 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Closed access
PDF file
XCXiaoling Cao
Xiaoling Cao
RYRong Yin
Rong Yin
HAHelmut Albrecht
Helmut Albrecht
DFDaping Fan
Daping Fan
Wenbin TanWenbin Tan
Wenbin Tan
The pandemic of coronavirus disease (COVID-19) has become a global threat to public health. Functional impairments in multiple organs have been reported in COVID-19, including lungs, heart, kidney, liver, brain, and vascular system. Patients with metabolic-associated preconditions, such as hypertension, obesity, and diabetes, are susceptible to experiencing severe symptoms. The recent emerging evidence of coagulation disorders in COVID-19 suggests that vasculopathy appears to be an independent risk factor promoting disease severity and mortality of affected patients. We recently found that the decreased levels of low-density lipoprotein cholesterols (LDL-c) correlate with disease severity in COVID-19 patients, indicating pathological interactions between dyslipidemia and vasculopothy in patients with COVID-19. However, this clinical manifestation has been unintentionally underestimated by physicians and scientific communities. As metabolic-associated morbidities are generally accompanied with endothelial cell (EC) dysfunctions, these pre-existing conditions may make ECs more vulnerable to SARS-CoV-2 attack. In this mini-review, we summarize the metabolic and vascular manifestations of COVID-19 with an emphasis on the association between changes in LDL-c levels and the development of severe symptoms as well as the pathophysiologic mechanisms underlying the synergistic effect of LDL-c and SARS-CoV-2 on EC injuries and vasculopathy.

13 October 2023 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
HXHailin Xu
Hailin Xu
HYHao Yang
Hao Yang
ZWZhiyong Wang
Zhiyong Wang
QTQizhi Tang
Qizhi Tang
XCXiaoling Cao
Xiaoling Cao
ZHzhicheng Hu
zhicheng Hu
The dysfunction of endothelial cells caused by hyperglycemia is observed as a decrease in neovascularization in diabetic wound healing. Studies have found that epidermal stem cells (EpiSCs) can promote the angiogenesis of full-thickness wounds. To further explain the therapeutic effect of EpiSCs, EpiSC-derived exosomes (EpiSC-EXOs) are considered the main substance contributing to stem cell effectivity. In our study, EpiSCs and EpiSC-EXOs were supplied to the dorsal wounds of db/db mice. Results showed that EpiSCs could colonize in the wound area and both EpiSCs and EpiSC-EXOs could accelerate diabetic wound healing by promoting angiogenesis. In vitro, persistent high glucose led to the malfunction and apoptosis of endothelial cells. The apoptosis induced by high glucose is due to excessive autophagy and was alleviated by EpiSC-EXOs. RNA sequencing of EpiSC-EXOs showed that miR200b-3p was enriched in EpiSC-EXOs and alleviated the apoptosis of endothelial cells. Synapse defective rho GTPase homolog 1 was identified the target of miR200b-3p and affected the phosphorylation of ERK to regulate intracellular autophagy and apoptosis. Furthermore, animal experiments validated the angiogenic effect of miR200b-3p. Collectively, our results verified the effect of EpiSC-EXOs on apoptosis caused by hyperglycemia in endothelial cells through the miR200b-3p/synapse defective rho GTPase homolog 1 /RAS/ERK/autophagy pathway, providing a theoretical basis for EpiSC in treating diabetic wounds.

26 November 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
DLDongming Lv
Dongming Lv
LRLei Ren
Lei Ren
ZZZirui Zhao
Zirui Zhao
YRYanchao Rong
Yanchao Rong
MCMiao Chen
Miao Chen
BTBing Tang
Bing Tang
Timely infiltration and effective turnover of macrophages after trauma are essential for wound regeneration. In pathological conditions, such as diabetic wounds, how disturbances in cellular collaboration leads to persistent inflammatory infiltration remains unclear. Herein, we identify that the expression of methionine adenosyltransferase 2 A (MAT2A), which is downregulated in pericytes, is negatively correlated with inflammatory macrophage infiltration in diabetic wounds. Cspg4-CreERT2/+; Mat2aflox/flox female mouse model and single-cell sequencing of its wound tissue reveal that TAM induced-Mat2a deficiency in pericytes induces cell senescence and further drives the inflammatory trained immunity of infiltrating macrophages through senescence-associated secretory phenotype factors and cellular mitochondrial transfer. Mechanistically, MAT2A downregulation in pericyte reduces the recruitment of the deubiquitinase OTUB1 to HMGCS1 and thus reduces HMGCS1 expression level, thereby interfering with coenzyme Q synthesis, affecting mitochondrial function, and inducing cell senescence. We then coat self-amplifying RNA-loaded nanoparticles with pericyte membrane to restore stable MAT2A expression in senescent pericytes, effectively alleviating the persistent inflammatory macrophage infiltration and promoting wound regeneration. Our results reveal MAT2A as a potential therapeutic target in chronic inflammatory wounds and suggest a targeting senotherapy based on a biomimetic strategy.

1 September 2026 in Wound Repair and Regeneration
Verified
Journal Article
Closed access
XCXiaoling Cao
Xiaoling Cao
HLHaibo Liu
Haibo Liu
DLDongming Lv
Dongming Lv
ZHzhicheng Hu
zhicheng Hu
ZXZhongye Xu
Zhongye Xu
RYRong Yin
Rong Yin